Literature DB >> 12192166

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.

Marta Luisa Ciofi Degli Atti1, Stefania Salmaso, Antonino Bella, Raffaele Arigliani, Michele Gangemi, Giampiero Chiamenti, Guido Brusoni, Alberto Eugenio Tozzi.   

Abstract

BACKGROUND: Planning and evaluating vaccination programs depend on reliable systems of monitoring disease incidence in the community. In Italy vaccine-preventable diseases are subject to statutory notification, but they are often unreported. In January, 2000, a pediatric sentinel network was launched, with the aim of monitoring in a timely and accurate way the geographic and temporal trends of vaccine-preventable diseases.
METHODS: The network consists of National Health System primary care pediatricians; participation is voluntary. The diseases under surveillance include measles, mumps, rubella, pertussis and varicella. Case definitions are based on specific clinical criteria, and pediatricians report cases on a monthly basis. Incidence rates are estimated and compared with those obtained by statutory notifications. The proportion of vaccinated cases is also computed.
RESULTS: In 2000 an average of 468 pediatricians participated each month of a total of 7276 pediatricians under contract for primary care by the National Health System. The population under surveillance consisted of 371 670 children younger than 15 years (of a national total of 8.347.804 children of the same age). The annual national incidence per 100.000 children was estimated at 5345 for varicella, 1972 for mumps, 279 for pertussis, 108 for rubella and 62 for measles, although wide variations were observed among geographic areas. The national estimates are 3 to 7 times higher than those obtained through statutory notifications. For all of the diseases the ratio between the two sources of data was significantly higher in southern Italy, compared with the rest of the country. The proportion of vaccinated cases was similar for measles and rubella (21 and 17%) but was approximately 3 times higher for mumps (59%). Most (74%) of the vaccinated mumps cases had received the Rubini vaccine strain.
CONCLUSIONS: The sentinel surveillance system is considerably more sensitive than statutory notifications, particularly in southern Italy. The high percentage of mumps cases vaccinated with the Rubini strain indicates a reduced effectiveness of this vaccine. Although further improvements are needed, pediatrician-based sentinel surveillance is a useful tool for evaluating vaccine-preventable disease trends.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192166     DOI: 10.1097/00006454-200208000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Clinical, social and relational determinants of paediatric ambulatory drug prescriptions due to respiratory tract infections in Italy.

Authors:  Marta Luisa Ciofi degli Atti; Marco Massari; Antonino Bella; Delia Boccia; Antonietta Filia; Stefania Salmaso
Journal:  Eur J Clin Pharmacol       Date:  2006-10-05       Impact factor: 2.953

2.  A 5-year comparison of performance of sentinel and mandatory notification surveillance systems for measles in Switzerland.

Authors:  Jean-Luc Richard; Beatriz Vidondo; Mirjam Mäusezahl
Journal:  Eur J Epidemiol       Date:  2007-09-26       Impact factor: 8.082

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

5.  Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Francesca Russo; Marta Cecilia Busana; Cinzia Piovesan; Greta Bordignon; Aurore Giliberti; Renzo Trivello
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

6.  Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.

Authors:  Jorien G J Pierik; Pearl D Gumbs; Sander A C Fortanier; Pauline C E Van Steenwijk; Maarten J Postma
Journal:  BMC Infect Dis       Date:  2012-05-10       Impact factor: 3.090

Review 7.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

8.  Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.

Authors:  Napoleón Pérez-Farinós; María Ordobás; Cristina García-Fernández; Luis García-Comas; Soledad Cañellas; Inmaculada Rodero; Angeles Gutiérrez-Rodríguez; Juan García-Gutiérrez; Rosa Ramírez
Journal:  BMC Infect Dis       Date:  2007-06-15       Impact factor: 3.090

9.  Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy.

Authors:  John R Williams; Piero Manfredi; Alisa R Butler; Marta Ciofi Degli Atti; Stefania Salmaso
Journal:  BMC Public Health       Date:  2003-07-18       Impact factor: 3.295

10.  Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.

Authors:  Roman Prymula; Robert Simko; Michael Povey; Andrea Kulcsar
Journal:  BMC Pediatr       Date:  2016-01-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.